Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Int J Radiat Oncol Biol Phys
    December 2024
  1. RUHLE A
    Stick Your Neck Out: Reirradiate or Not in a Head and Neck Cancer Patient With Extracapsular Extension After Salvage Neck Dissection.
    Int J Radiat Oncol Biol Phys. 2024;120:1205-1206.
    >> Share

    November 2024
  2. THARIAT J, Bosset M, Falcoz A, Vernerey D, et al
    Survival without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial in Head and Neck Cancer Patients with Oligometastases using Stereotactic Ablative Radiotherapy (SABR)-alone or chemotherapy SABR.
    Int J Radiat Oncol Biol Phys. 2024 Nov 27:S0360-3016(24)03651.
    >> Share

  3. LUO X, Wang H, Xu J, Li L, et al
    Generalizable MRI-based Nasopharyngeal Carcinoma Delineation: Bridging Gaps across Multiple Centers and Raters with Active Learning.
    Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03644.
    >> Share

  4. WANG L, Wang J, Wang T, Li Y, et al
    The Role of Elective Nodal Irradiation in Treating Clinically Node-Negative Sinonasal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024;120:1058-1065.
    >> Share

  5. MCDOWELL L, King MT, Hutcheson KA, Ringash J, et al
    A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials.
    Int J Radiat Oncol Biol Phys. 2024;120:805-822.
    >> Share

  6. ALEXANDER J, Beatty A
    Association of Patient Portal Messaging with Survival Among Radiation Oncology Patients.
    Int J Radiat Oncol Biol Phys. 2024;120:627-638.
    >> Share

  7. VAN RIJN-DEKKER MI, la Bastide-van Gemert S, Stokman MA, Vissink A, et al
    Radiation-induced Xerostomia is Related to Stem Cell Dose-dependent Reduction of Saliva Production.
    Int J Radiat Oncol Biol Phys. 2024;120:772-782.
    >> Share

    October 2024
  8. ZHANG X, Yan J, Lei Q, Neo J, et al
    A Randomised, Multicentre, Phase II Trial of Camrelizumab with or without Metastasis-directed Stereotactic Body Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Oct 23:S0360-3016(24)03512.
    >> Share

  9. JABBOUR SK, Higgins KA, Yom SS, Goodman KA, et al
    Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2024;120:309-314.
    >> Share

  10. LIAN B, Yang Y, Zheng B, Si L, et al
    Efficacy and Safety of Postoperative Adjuvant Radiation Therapy in Resected Nasal Cavity and Paranasal Sinus Mucosal Melanoma: A Combined Analysis.
    Int J Radiat Oncol Biol Phys. 2024;120:528-536.
    >> Share

    September 2024
  11. CAI G, Wang K, Zhao J, Huang B, et al
    Predictive value of changes in basal myocardial (18)F-fluorodeoxyglucose uptake for cardiotoxicity in locally advanced esophageal cancer patients receiving definitive radiotherapy.
    Int J Radiat Oncol Biol Phys. 2024 Sep 20:S0360-3016(24)03403.
    >> Share

  12. CHARTERS E, Davies S, Sharman AR, Milross C, et al
    Keeping Swallowing on Track During Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:29-32.
    >> Share

  13. JACOMINA LE, Moreno AC
    Management of Patients With Early-Stage Oropharyngeal Cancer With Clinically Positive Retropharyngeal Lymph Nodes.
    Int J Radiat Oncol Biol Phys. 2024;120:13-14.
    >> Share

  14. WOODY NM
    Spare the Knife When Retropharyngeal Lymph Nodes Are Present in Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:13.
    >> Share

    August 2024
  15. CHU H, de Vette SPM, Neh H, Sijtsema NM, et al
    3D deep learning Normal Tissue Complication Probability model to predict late xerostomia in head and neck cancer patients.
    Int J Radiat Oncol Biol Phys. 2024 Aug 13:S0360-3016(24)03172.
    >> Share

  16. LIN C, Stevens M
    Mandatory Organ Preservation: Adenoid Cystic Carcinoma of the Trachea.
    Int J Radiat Oncol Biol Phys. 2024;119:1334-1335.
    >> Share

  17. DOU S, Zhu G
    Adenoid Cystic Carcinoma in the Trachea: When Surgery is Not Feasible.
    Int J Radiat Oncol Biol Phys. 2024;119:1333-1334.
    >> Share

  18. XING TD, Corry J
    A Rare Cancer Arising in an Uncommon Site: Treatment of Adenoid Cystic Carcinoma of the Trachea.
    Int J Radiat Oncol Biol Phys. 2024;119:1331-1332.
    >> Share

  19. HOSSEINIAN S, Hemmati M, Dede C, Salzillo TC, et al
    Cluster-Based Toxicity Estimation of Osteoradionecrosis Via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification.
    Int J Radiat Oncol Biol Phys. 2024;119:1569-1578.
    >> Share

  20. LEAVITT RJ, Almeida A, Grilj V, Montay-Gruel P, et al
    Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;119:1493-1505.
    >> Share

  21. ARISTOPHANOUS M, Aliotta E, Lichtenwalner P, Abraham S, et al
    Clinical Experience With an Offline Adaptive Radiation Therapy Head and Neck Program: Dosimetric Benefits and Opportunities for Patient Selection.
    Int J Radiat Oncol Biol Phys. 2024;119:1557-1568.
    >> Share

    July 2024
  22. NORONHA V, Patil V, Menon N, Singh A, et al
    Long term update of a phase 3 randomized study comparing once-a-week versus once-every-3-weeks cisplatin along with radiation in head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2024 Jul 27:S0360-3016(24)03139.
    >> Share

  23. SHER DJ, Avkshtol V, Moon D, Vo D, et al
    Stereotactic ablative radiotherapy for T1-2 glottic larynx cancer: mature results from the phase II LT-SABR trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 20:S0360-3016(24)02972.
    >> Share

  24. LI JS, Blanchard P, Wong CHL, Ahn YC, et al
    International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024 Jul 13:S0360-3016(24)02954.
    >> Share

  25. LI W, Zhao D, Zeng G, Chen Z, et al
    Evaluating Virtual Contrast-enhanced MRI (VCE-MRI) in Nasopharyngeal Carcinoma Radiotherapy: A Retrospective Analysis for Primary Gross Tumor Delineation.
    Int J Radiat Oncol Biol Phys. 2024 Jul 2:S0360-3016(24)00750.
    >> Share

  26. KATADA C, Yokoyama T, Watanabe A, Hara H, et al
    Optimizing Organ Preservation Strategies through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results from the CROC Multi-Institutional Phase II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 2:S0360-3016(24)00752.
    >> Share

  27. MORSE RT, Mell LK
    Hypoxic Cell Radiosensitization in Head and Neck Squamous Cell Carcinoma: Running Out of Air.
    Int J Radiat Oncol Biol Phys. 2024;119:783-785.
    >> Share

  28. WILKE C, Henson C, Huang SH, Bakst RL, et al
    Optimizing Therapy: The Art and Science of Modern Head and Neck Radiation.
    Int J Radiat Oncol Biol Phys. 2024;119:709-715.
    >> Share

  29. LI M, Sun H, Yang W, Luo J, et al
    A Phase 1b Clinical Trial of Neoadjuvant Radio-immunotherapy for Esophageal Squamous Cell Cancer.
    Int J Radiat Oncol Biol Phys. 2024;119:896-901.
    >> Share

    June 2024
  30. CHEN B, Chen W, Cheng Q, Zhang H, et al
    Comparison of efficacy and safety of combined chemoimmunotherapy with or without radiotherapy for stage IVB esophageal squamous cell carcinoma: a multicenter propensity score matching analysis.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00741.
    >> Share

  31. ZHANG Z, Zhang J, Zheng R, Ye J, et al
    A Population-Based Tumor-Volume Model for Head-and-Neck Cancer During Radiotherapy with a Dynamic Oxygenated Compartment.
    Int J Radiat Oncol Biol Phys. 2024 Jun 11:S0360-3016(24)00684.
    >> Share

  32. MILGROM SA, van Luijk P, Pino R, Ronckers CM, et al
    Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:467-481.
    >> Share

    May 2024
  33. CHU Y, Zhu C, Hobbs BP, Chen Y, et al
    Personalized Composite Dosimetric Score-Based Machine Learning Model of Severe Radiation-Induced Lymphopenia among Esophageal Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00668.
    >> Share

  34. MCVORRAN S, Naghavi A, Schaner P
    Putting the Brakes on Xerostomia in Oropharyngeal Cancer: Can Brachytherapy Be the Key?
    Int J Radiat Oncol Biol Phys. 2024;119:302-303.
    >> Share

    April 2024
  35. SMITH J, Margalit D, Golledge J, Nastasi D, et al
    Carotid Artery Stenosis and Ischemic Stroke in Patients with Head and Neck Cancer Treated with Radiotherapy: A Critical Review.
    Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00474.
    >> Share

  36. HIROSE K, Sato M
    Clinical Results and Prognostic Factors in BNCT for Recurrent Squamous Cell Carcinoma of the Head and Neck under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients.
    Int J Radiat Oncol Biol Phys. 2024 Apr 3:S0360-3016(24)00466.
    >> Share

  37. HOMMA A, Mikami M, Matsuura K, Onimaru R, et al
    Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients wi
    Int J Radiat Oncol Biol Phys. 2024;118:1271-1281.
    >> Share

  38. BUDRUKKAR A, Murthy V, Kashid S, Swain M, et al
    Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2024;118:1541-1551.
    >> Share

    March 2024
  39. YOUSSEF I, Mohamed N, Kallini D, Zakeri K, et al
    An Analysis of PET Maximum SUV Among Head and Neck Cancer Patients Receiving Photon and Proton Radiation.
    Int J Radiat Oncol Biol Phys. 2024 Mar 16:S0360-3016(24)00428.
    >> Share

  40. CHEN M, Wang K, Wang J
    Vision Transformer-Based Multilabel Survival Prediction for Oropharynx Cancer After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1123-1134.
    >> Share

  41. DENG J, Dietrich MS, Aulino JM, Sinard RJ, et al
    Longitudinal Pattern of Lymphedema and Fibrosis in Patients With Oral Cavity or Oropharyngeal Cancer: A Prospective Study.
    Int J Radiat Oncol Biol Phys. 2024;118:1029-1040.
    >> Share

  42. MCDOWELL L, Gough K, Fua T, Coleman A, et al
    A Longitudinal Study Evaluating Sexual Health Outcomes and Prioritization in Patients Undergoing Chemoradiation for Human Papillomavirus-Associated Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:1018-1028.
    >> Share

  43. MOWERY YM
    Cautionary Tale: Excess Toxicity With DNA-Dependent Protein Kinase Inhibitor and Concurrent Cisplatin-Based Chemoradiation for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:757-758.
    >> Share

  44. SAMUELS M, Falkenius J, Bar-Ad V, Dunst J, et al
    A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors.
    Int J Radiat Oncol Biol Phys. 2024;118:743-756.
    >> Share

  45. ZHANG S, Li K, Sun Y, Wan Y, et al
    Deep learning for automatic gross tumor volumes contouring in esophageal cancer based on contrast-enhanced CT images: a multi-institutional study.
    Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00350.
    >> Share

    February 2024
  46. DE BRUYCKER A, De Neve W, Daisne JF, Vercauteren T, et al
    Disease control and late toxicity in Adaptive Dose Painting by Numbers vs. non-adaptive radiotherapy for head and neck cancer: a randomized controlled phase II trial.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00025.
    >> Share

  47. ADAM DP, Grudzinski JJ, Marsh IR, Hill PM, et al
    Voxel-level dosimetry for combined Iodine-131 radiopharmaceutical therapy and external beam radiotherapy treatment paradigms of head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 15:S0360-3016(24)00308.
    >> Share

  48. BRITTON B, Baker AL, Wolfenden L, Wratten C, et al
    Five-year mortality outcomes for Eating As Treatment (EAT), a health behaviour change intervention to improve nutrition in patients with head and neck cancer: a stepped-wedge, randomised controlled trial.
    Int J Radiat Oncol Biol Phys. 2024 Feb 4:S0360-3016(24)00248.
    >> Share

  49. GLASER S
    Nodal Recurrence of Uterine Cancer: A Growing Problem.
    Int J Radiat Oncol Biol Phys. 2024;118:319.
    >> Share

  50. LOUATI S, Wozny AS, Malesys C, Daguenet E, et al
    Differential Formation of Stress Granules in Radiosensitive and Radioresistant Head and Neck Squamous Cell Carcinoma Cells.
    Int J Radiat Oncol Biol Phys. 2024;118:485-497.
    >> Share

    January 2024
  51. HUISKES M, Kong W, Oud M, Crama K, et al
    Validation of Fully Automated Robust Multicriterial Treatment Planning for Head and Neck Cancer IMPT.
    Int J Radiat Oncol Biol Phys. 2024 Jan 27:S0360-3016(23)08308.
    >> Share

  52. HAHN E, Huang SH
    Leveraging the Potential of Induction Therapy in Human Papillomavirus-Mediated Oropharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024;118:179-181.
    >> Share

  53. LESTER SC, Moon DH, Patel SH, Awan MJ, et al
    Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:165-168.
    >> Share

  54. XU T, Shen C, Zhou X, Zhu L, et al
    Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IC
    Int J Radiat Oncol Biol Phys. 2024;118:169-178.
    >> Share

  55. MERCADANTE V, Hamad AA, McCaul J, Nutting C, et al
    Salivary Electrostimulation in the Treatment of Radiation Therapy-Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2024;118:142-153.
    >> Share

    December 2023
  56. HANNA GJ, Chang SS, Siddiqui F, Bain PA, et al
    Imaging and Biomarker Surveillance for Head and Neck Squamous cell carcinoma: A Systematic Review and Appropriate Use Criteria Document.
    Int J Radiat Oncol Biol Phys. 2023 Dec 31:S0360-3016(23)08258.
    >> Share

  57. DUAN Y, Wang J, Wu P, Chen H, et al
    AS-NeSt: a Novel 3D Deep Learning Model for Radiotherapy Dose Distribution Prediction on Esophageal Cancer Treatment with Multiple Prescriptions.
    Int J Radiat Oncol Biol Phys. 2023 Dec 28:S0360-3016(23)08239.
    >> Share

  58. ODHIAMBO DA, Pittman AN, Rickard AG, Castillo RJ, et al
    Preclinical Evaluation of the ATR inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Dec 15:S0360-3016(23)08244.
    >> Share

  59. THOMSON PD, Slevin PN, Baines H, Betts G, et al
    Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD).
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08184.
    >> Share

  60. KODAIRA T, Kagami Y, Machida R, Shikama N, et al
    Long-Term Follow-up of a Randomized Controlled Trial on Accelerated Radiation Therapy Versus Standard Fractionated Radiation Therapy for Early Glottic Cancer (JCOG0701A3).
    Int J Radiat Oncol Biol Phys. 2023;117:1118-1124.
    >> Share

  61. KYAW JYA, Rendall A, Gillespie EF, Roques T, et al
    Systematic Review and Meta-analysis of the Association Between Radiation Therapy Treatment Volume and Patient Outcomes.
    Int J Radiat Oncol Biol Phys. 2023;117:1063-1086.
    >> Share

    November 2023
  62. HAHN E, Ng WT
    Small Changes, Big Impact: Excitement and Caution in Dose and Volume Reduction for Nasopharyngeal Carcinoma Radiation Therapy After Induction Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2023;117:925-927.
    >> Share

  63. VASQUEZ OSORIO E, Abravan A, Green A, van Herk M, et al
    Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem.
    Int J Radiat Oncol Biol Phys. 2023;117:903-913.
    >> Share

  64. RAZAVIAN NB, D'Agostino RB Jr, Shenker RF, Hughes RT, et al
    Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2023;117:652-663.
    >> Share

    October 2023
  65. RUHLE A, Weymann M, Behrens M, Marschner S, et al
    A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08025.
    >> Share

  66. RINGASH J, Dunphy C, Avery L, Chahin R, et al
    Efficacy of the rehabilitation planning consult for survivors of head and neck cancer: A phase II randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07957.
    >> Share

  67. DUPERE JM, Lucido JJ, Breen WG, Mahajan A, et al
    Pencil beam scanning proton therapy for pregnant patients with brain and head and neck cancers.
    Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07953.
    >> Share

  68. SCHOENFELD JD
    Proceed With Caution: Eliminating Elective Nodal Irradiation With Immunotherapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:355-356.
    >> Share

  69. MA TM, Wong DJ, Chai-Ho W, Mendelsohn A, et al
    High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2023;117:348-354.
    >> Share

  70. GARDEN AS, Harris J, Eisbruch A, Chao KSC, et al
    Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:333-340.
    >> Share

    September 2023
  71. MOWERY YM
    Splitting the Difference With Intensified Radiation Therapy Alone for Borderline Early Stage Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:9.
    >> Share

  72. DE LEO AN, Dagan R
    Early Glottic Cancer With Adverse Features: Can Larynx-Only RT Cut It Without Needing to Eventually Cut It Out?
    Int J Radiat Oncol Biol Phys. 2023;117:6-7.
    >> Share

  73. ALLEN SG, Rosen BS, Aryal M, Cao Y, et al
    Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of (18)F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim Analysis.
    Int J Radiat Oncol Biol Phys. 2023;117:171-180.
    >> Share

    August 2023
  74. WANG X, van Rossum PSN, Chu Y, Hobbs BP, et al
    Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023 Aug 29:S0360-3016(23)07852.
    >> Share


  75. Erratum to: Caudell JJ, Torres-Saavedra PA, Rosenthal DI, Axelrod RS, et al. Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Aug 11:S0360-3016(23)07642.
    >> Share

  76. MILLER ED, Wu T, McKinley G, Slivnick J, et al
    Incident Atrial Fibrillation and Survival Outcomes in Esophageal Cancer following Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Aug 11:S0360-3016(23)07748.
    >> Share

  77. MCDOWELL L, Bressel M, King MT, Corry J, et al
    Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A TROG 12.01 Secondary Analysis.
    Int J Radiat Oncol Biol Phys. 2023;116:1110-1125.
    >> Share

    July 2023
  78. BONOMI M, Blakaj DM, Kabarriti R, Colvett K, et al
    PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2023;116:551-559.
    >> Share

    June 2023
  79. MOON DH, Avkshtol V, Vo D, Ahn C, et al
    HYPORT: Phase I study of three-week hypofractionated post-operative radiation therapy for head and neck squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Jun 26:S0360-3016(23)00600.
    >> Share

  80. XIANG L, Rong JF, Chen X, Li XY, et al
    Reducing Target Volumes of Intensity-Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2023 Jun 23:S0360-3016(23)00585.
    >> Share

  81. YANG Y, Feng T, Fan X, Wang C, et al
    Genomic and transcriptomic remodelling by neoadjuvant chemoradiotherapy (nCRT) and indicative role of acquired INDEL percentage for nCRT efficacy in esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Jun 18:S0360-3016(23)00588.
    >> Share

    May 2023
  82. HENG J, Li Z, Liu L, Zheng Z, et al
    Acetyl-CoA Acetyltransferase 2 Confers Radioresistance by Inhibiting Ferroptosis in Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 May 25:S0360-3016(23)00519.
    >> Share

  83. PAPE M, Veen LM, Smit TM, Kuijper SC, et al
    Late toxicity and health-related quality of life following definitive chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2023 May 22:S0360-3016(23)00512.
    >> Share

  84. GAO T, Yang Y, Zhang Z, Yang Y, et al
    A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: a Re-analysis of Data from the NEOCRTEC5010 Trial.
    Int J Radiat Oncol Biol Phys. 2023 May 18:S0360-3016(23)00497.
    >> Share

  85. VAN RIJN DEKKER MI, van Luijk P, Schuit E, van der Schaaf A, et al
    Prediction of radiation-induced parotid gland-related xerostomia in head and neck cancer patients: regeneration-weighted dose.
    Int J Radiat Oncol Biol Phys. 2023 May 5:S0360-3016(23)00437.
    >> Share

  86. DIAO K, Lei X, Smith GL, Jagsi R, et al
    Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2023;116:142-153.
    >> Share

  87. DAR MA, Chauhan R, Trivedi V, Kumar R, et al
    Assessing the Prevalence of Financial Toxicity, its Predictors and Association with Health- Related Quality of Life Among Radiation Oncology Patients in India: A Cross-Sectional Patient Reported Outcome Study.
    Int J Radiat Oncol Biol Phys. 2023;116:157-165.
    >> Share

    April 2023
  88. ISOZAKI T, Ishikawa H, Yasuda S, Isozaki Y, et al
    A Phase I/II Trial of Definitive Carbon Ion Radiotherapy for Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Apr 26:S0360-3016(23)00378.
    >> Share

  89. ECHEVARRIA MI, Yang GQ, Chen DT, Kirtane K, et al
    Phase I dose escalation of stereotactic body radiation therapy and concurrent cisplatin for re-irradiation of unresectable, recurrent squamous cell carcinoma of the head and neck.
    Int J Radiat Oncol Biol Phys. 2023 Apr 25:S0360-3016(23)00366.
    >> Share

  90. ALI AS, Msanukian G, Johnson JM, Vathiotis I, et al
    In-field toxicity analysis of a phase I clinical trial of nivolumab and ipilimumab with definitive radiation therapy in locally advanced squamous cell carcinoma of the head and neck: In-Field toxicity of immune-RT in LA-SCCHN.
    Int J Radiat Oncol Biol Phys. 2023 Apr 3:S0360-3016(23)00309.
    >> Share

  91. TAM A, Amini A
    Management After an Initial Nononcologic Approach to an HPV+ Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2023;115:1026.
    >> Share

  92. BEITLER JJ, Sen N
    T1N1M0 + p16 Squamous Cell Cancer of Base of Tongue With 3.6-cm Node and <1 mm of ENE.
    Int J Radiat Oncol Biol Phys. 2023;115:1027-1028.
    >> Share

  93. VAN BRUGGEN IG, Huiskes M, de Vette SPM, Holmstrom M, et al
    Automated Robust Planning for IMPT in Oropharyngeal Cancer Patients Using Machine Learning.
    Int J Radiat Oncol Biol Phys. 2023;115:1283-1290.
    >> Share

  94. YANG SS, OuYang PY, Guo JG, Cai JJ, et al
    Dosiomics Risk Model for Predicting Radiation Induced Temporal Lobe Injury and Guiding Individual Intensity-Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;115:1291-1300.
    >> Share

    March 2023
  95. BRISSON RJ, Holtzman AL
    Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule.
    Int J Radiat Oncol Biol Phys. 2023;115:817-818.
    >> Share

  96. MCDONALD MW, Bates JE, McCall NS, Goyal S, et al
    Insurance authorization and access to proton therapy for patients with head and neck cancers.
    Int J Radiat Oncol Biol Phys. 2023 Mar 6:S0360-3016(23)00178.
    >> Share

    January 2023
  97. MA SJ, Iovoli AJ, Wang K, Neimanis D, et al
    Efficacy of Prophylactic High-Dose Gabapentin and Venlafaxine on Reducing Oral Mucositis Pain Among Patients Treated with Chemoradiation for Head and Neck Cancer: A Single-Institution, Phase II, Randomized Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2023 Jan 31:S0360-3016(23)00084.
    >> Share

  98. DING M, Cui H, Li B, Zou B, et al
    Integrating preoperative CT and clinical factors for lymph node metastasis prediction in esophageal squamous cell carcinoma (ESCC) by feature-wise attentional graph neural network (FAGNN).
    Int J Radiat Oncol Biol Phys. 2023 Jan 11:S0360-3016(23)00002.
    >> Share

  99. WU Y, Qian Y
    Treatment for Radiation-Recall Mucositis Induced by Anti-PD-1 Blockade.
    Int J Radiat Oncol Biol Phys. 2023;115:7-8.
    >> Share

  100. SHERER MV, Sher DJ
    Patient-Reported Outcomes After Unilateral Treatment for Human Papillomavirus-Associated Tonsillar Cancer: Overrated or Still Overtreated?
    Int J Radiat Oncol Biol Phys. 2023;115:189-191.
    >> Share

  101. ANDERSON JD, DeWees TA, Ma DJ, Nagel TH, et al
    A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2023;115:192-201.
    >> Share

  102. MCDOWELL L, Rischin D, King M, Kenny L, et al
    Patient- and Clinician-Reported Outcomes in Human Papillomavirus-Associated Tonsillar Carcinoma Treated With Unilateral and Bilateral Intensity Modulated Radiation Therapy-A Substudy From TROG 12.01.
    Int J Radiat Oncol Biol Phys. 2023;115:174-188.
    >> Share

    December 2022
  103. HUANG CL, Qiu YY, Du XJ, Wang GY, et al
    Upper-neck versus whole-neck irradiation at the contralateral uninvolved neck in patients with unilateral N3 nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Dec 31:S0360-3016(22)03694.
    >> Share

  104. CAUDELL JJ, Torres-Saavedra PA, Rosenthal DI, Axelrod RS, et al
    Long-term update of NRG/RTOG 0522: a randomized phase III trial of concurrent radiation and cisplatin with or without cetuximab in locoregionally advanced head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2022 Dec 19:S0360-3016(22)03636.
    >> Share

  105. FU S, Li Y, Han Y, Wang H, et al
    Erratum to: Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical T
    Int J Radiat Oncol Biol Phys. 2022;114:1055-1056.
    >> Share

    November 2022
  106. QIAN DC, Ulrich BC, Peng G, Zhao H, et al
    Outcomes stratification of head and neck cancer using pre- and post-treatment DNA methylation from peripheral blood.
    Int J Radiat Oncol Biol Phys. 2022 Nov 18:S0360-3016(22)03521.
    >> Share

  107. YOU J, Zhu S, Li J, Li J, et al
    High-dose versus standard-dose intensity-modulated radiotherapy with concurrent paclitaxel plus carboplatin for patients with thoracic esophageal squamous cell carcinoma: a randomized, multicenter, open-label, phase 3 superiority trial.
    Int J Radiat Oncol Biol Phys. 2022 Nov 16:S0360-3016(22)03520.
    >> Share

  108. NAKAJIMA S, Mimura K, Kaneta A, Saito K, et al
    Radiation-induced remodeling of the tumor-microenvironment through tumor cell-intrinsic expression of cGAS-STING in esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Nov 8. pii: S0360-3016(22)03512.
    >> Share

  109. REYES EG, Tonse R, Chundru S, Kaiser A, et al
    Variable Relative Biological Effectiveness of Proton Therapy Increases PET Visible Mucosal Injury in Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2022 Nov 8. pii: S0360-3016(22)03508.
    >> Share

  110. SHARMA AK
    Adjuvant Head and Neck Radiation in a Young Pregnant Woman.
    Int J Radiat Oncol Biol Phys. 2022;114:382.
    >> Share

    October 2022
  111. GILLISON ML, Ferris RL, Harris J, Colevas AD, et al
    Safety of nivolumab added to chemoradiotherapy platforms for intermediate and high-risk local-regionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504.
    Int J Radiat Oncol Biol Phys. 2022 Oct 10. pii: S0360-3016(22)03434.
    >> Share

  112. PRICE K, Van Abel KM, Moore EJ, Patel SH, et al
    Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;114:256-265.
    >> Share

    September 2022
  113. LI L, Sun J, Liu N, Yu R, et al
    Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 Sep 24. pii: S0360-3016(22)02594.
    >> Share

  114. BEADLE BM, Bauman JE
    Reconsidering How It Begins: Response to Gray Zone Article About Head and Neck Cancer in a Young Pregnant Woman.
    Int J Radiat Oncol Biol Phys. 2022 Sep 21. pii: S0360-3016(22)03321.
    >> Share

  115. NELSON B, Takiar V
    Low Risk, High Risk: Adjuvant Therapy in Resected p16+ Oropharyngeal Cancer with >/=5 Positive Ipsilateral Lymph Nodes.
    Int J Radiat Oncol Biol Phys. 2022;114:10-11.
    >> Share

    August 2022
  116. CAI G, Li C, Li J, Yang J, et al
    Cardiac Substructures Dosimetric Predictors for Cardiac Toxicity After Definitive Radiotherapy in Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Aug 13. pii: S0360-3016(22)03105.
    >> Share

  117. TAKEUCHI H, Ito Y, Machida R, Kato K, et al
    A Single-Arm Confirmatory Study of Definitive Chemoradiotherapy Including Salvage Treatment for Clinical Stage II/III Esophageal Squamous Cell Carcinoma (JCOG0909 Study).
    Int J Radiat Oncol Biol Phys. 2022 Aug 3. pii: S0360-3016(22)00726.
    >> Share

  118. TAKU N, Chronowski G, Brandon Gunn G, Morrison WH, et al
    Unilateral Radiation Therapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papillomavirus, Positron-Emission Tomography, and Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;113:1054-1062.
    >> Share

    July 2022
  119. MOON DH, Sher DJ
    Oligometastasis in head and neck squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Jul 4. pii: S0360-3016(22)00660.
    >> Share

  120. BHIDE S
    Circulating Human Papillomavirus DNA as a Marker of Minimally Residual Disease After Surgery for Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:539-541.
    >> Share

  121. FNAIS N, Laxague F, Alzahrani F, Fung K, et al
    The Impact of Surgical Resectability on Outcomes for Patients Undergoing Primary Radiation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:521-529.
    >> Share

  122. SHINYA Y, Hasegawa H, Shin M, Kawashima M, et al
    High Dose Radiosurgery Targeting the Primary Tumor Sites Contributes to Survival in Patients With Skull Base Chordoma.
    Int J Radiat Oncol Biol Phys. 2022;113:582-587.
    >> Share

  123. ROUTMAN DM, Kumar S, Chera BS, Jethwa KR, et al
    Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;113:530-538.
    >> Share

    June 2022
  124. ANDERSON CM, Lee CM, Saunders D, Curtis AE, et al
    Two-Year Tumor Outcomes of Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiation Therapy and Ciplatin for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 17. pii: S0360-3016(22)00608.
    >> Share

  125. TAYLOR CL, Price JM
    The Tooth Hurts: Dental Health After Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:331-334.
    >> Share

  126. MCDOWELL L, Chua MLK, Beadle BM, Ma DJ, et al
    A Bit More Here and a Little Less There: The Trials (and Tribulations) of Adjuvant and Neoadjuvant Head and Neck Studies in 2021.
    Int J Radiat Oncol Biol Phys. 2022;113:243-251.
    >> Share

  127. CARDENAS CE, Blinde SE, Mohamed ASR, Ng SP, et al
    Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study.
    Int J Radiat Oncol Biol Phys. 2022;113:426-436.
    >> Share

  128. SCHRODER C, Kothe A, De Angelis C, Basler L, et al
    NTCP Modeling for High-Grade Temporal Radionecroses in a Large Cohort of Patients Receiving Pencil Beam Scanning Proton Therapy for Skull Base and Head and Neck Tumors.
    Int J Radiat Oncol Biol Phys. 2022;113:448-455.
    >> Share

    May 2022
  129. LIU X, Guo L, Xie FY, Hu WH, et al
    Necrosis in a Biomarker-driven, Phase 2 Trial of Adjuvant Apatinib in Patients of Nasopharyngeal Carcinoma with Residual Epstein-Barr Virus DNA after Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 May 9. pii: S0360-3016(22)00410.
    >> Share

  130. BUCKSTEIN MH, Anker CJ, Chuong MD, Hawkins MA, et al
    CROSSing into New Therapies for Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:5-10.
    >> Share

  131. NG SP, Corry J, Ng WT
    The Janus Face in Defining the Optimal Radiation Dose for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;113:114-116.
    >> Share

  132. PAKKANEN P, Irjala H, Ilmarinen T, Halme E, et al
    Survival and Larynx Preservation in Early Glottic Cancer: A Randomized Trial Comparing Laser Surgery and Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;113:96-100.
    >> Share

    April 2022
  133. WARD MC, Koyfman SA, Bakst RL, Margalit DN, et al
    Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society(R) (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Apr 7. pii: S0360-3016(22)00280.
    >> Share

  134. LU DJ, Luu M, Gay C, Nguyen AT, et al
    Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931.
    Int J Radiat Oncol Biol Phys. 2022 Apr 5. pii: S0360-3016(22)00279.
    >> Share

  135. LIAO W, He J, Luo X, Wu M, et al
    Automatic delineation of gross tumor volume based on magnetic resonance imaging by performing a novel semi-supervised learning framework in nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Apr 2. pii: S0360-3016(22)00277.
    >> Share

  136. HE L, Pi Y, Li Y, Wu Y, et al
    Efficacy and safety of apatinib in radiation-induced brain injury among head and neck cancer: an open-label, single-arm, phase 2 study.
    Int J Radiat Oncol Biol Phys. 2022 Apr 1. pii: S0360-3016(22)00268.
    >> Share

  137. QIU Y, Hu W, Wen M, Zhao W, et al
    Low Expression of ECT2 Confers Radiation Therapy Resistance Through Transcription Coupled Nucleolar DNA Damage Repair.
    Int J Radiat Oncol Biol Phys. 2022;112:1229-1242.
    >> Share

    March 2022
  138. MCDOWELL L, Bossi P
    The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?
    Int J Radiat Oncol Biol Phys. 2022;112:938-941.
    >> Share

  139. HU K, Persky M
    Depth of Invasion in Oral Tongue Cancer and Risk of Regional Failure.
    Int J Radiat Oncol Biol Phys. 2022;112:851-852.
    >> Share

  140. KILIC SS, Campbell SR
    Don't Take the Bait, Radiate: Importance of Adjuvant Radiation Therapy for Oral Tongue Cancer.
    Int J Radiat Oncol Biol Phys. 2022;112:850.
    >> Share

  141. HARA JHL, Juloori A
    Node Out, About It? Consideration of Adjuvant Treatment of Oral Tongue Cancer.
    Int J Radiat Oncol Biol Phys. 2022;112:849.
    >> Share

  142. COOK A, Modh A, Ali H, Sheqwara J, et al
    Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;112:926-937.
    >> Share

  143. NI R, Zhou T, Ren G, Zhang Y, et al
    Deep learning-based automatic assessment of radiation dermatitis in nasopharyngeal carcinoma (NPC) patients.
    Int J Radiat Oncol Biol Phys. 2022 Mar 15. pii: S0360-3016(22)00244.
    >> Share

  144. LI Y, Sakai M, Tsunoda A, Kubo N, et al
    Normal Tissue Complication Probability Model for Acute Radiation Dermatitis in Patients with Head and Neck Cancer Treated with Carbon Ion Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 Mar 9. pii: S0360-3016(22)00195.
    >> Share

  145. JOHUNG KL, Park HS
    Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control.
    Int J Radiat Oncol Biol Phys. 2022;112:585.
    >> Share

    January 2022
  146. FU S, Li Y, Han Y, Wang H, et al
    Diffusion-weighted MRI-guided dose painting in patients with locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus concurrent chemoradiotherapy: a randomized, controlled clinical trial.
    Int J Radiat Oncol Biol Phys. 2022 Jan 21. pii: S0360-3016(22)00001.
    >> Share

    December 2021
  147. BRENNAN MT, Treister NS, Sollecito TP, Schmidt BL, et al
    Tooth failure post-radiotherapy in head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2021 Dec 5. pii: S0360-3016(21)03219.
    >> Share

  148. YEOH KW, Yong FY
    Combined Modality Therapy in Extranodal NK/T Cell Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:1103-1105.
    >> Share

  149. THOMAS HR, Yom SS
    Right on the Nose: A Case of Locally Invasive Extranodal Lymphoma.
    Int J Radiat Oncol Biol Phys. 2021;111:1101-1102.
    >> Share

  150. CORRY J, Ng WT, Moore A, Choi HCW, et al
    Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study.
    Int J Radiat Oncol Biol Phys. 2021;111:1227-1236.
    >> Share

  151. TOMASIK B, Papis-Ubych A, Stawiski K, Fijuth J, et al
    Serum MicroRNAs as Xerostomia Biomarkers in Patients With Oropharyngeal Cancer Undergoing Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:1237-1249.
    >> Share

    November 2021
  152. RINGASH J
    Have We Tipped the Balance in HPV-Associated Oropharyngeal Cancer?: The Patient-Experience Side of the De-Escalation Balance Scale.
    Int J Radiat Oncol Biol Phys. 2021;111:887-889.
    >> Share

  153. CASSWELL G, Gough K, Drosdowsky A, Bressel M, et al
    Fear of Cancer Recurrence in Survivors of Human Papillomavirus-Associated Oropharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111:890-899.
    >> Share

  154. LI X, Gao H, Zhu J, Huang Y, et al
    3D Deep Learning Model for the Pretreatment Evaluation of Treatment Response in Esophageal Carcinoma: A Prospective Study (ChiCTR2000039279).
    Int J Radiat Oncol Biol Phys. 2021;111:926-935.
    >> Share

  155. RISCHIN D, King M, Kenny L, Porceddu S, et al
    Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study.
    Int J Radiat Oncol Biol Phys. 2021;111:876-886.
    >> Share

  156. LI W, Xiao H, Li T, Ren G, et al
    Virtual Contrast-enhanced Magnetic Resonance Images Synthesis for Patients with Nasopharyngeal Carcinoma using Multimodality-guided Synergistic Neural Network.
    Int J Radiat Oncol Biol Phys. 2021 Nov 11. pii: S0360-3016(21)03115.
    >> Share

  157. WANG Y, Thomas TV, Duggar WN, Roberts PR, et al
    Automatic Extracapsular Extension Identification in Head and Neck Cancer Using Deep Neural Network with Local-Global Information.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  158. ZHU Z, Ho TY, Jin D, Yan K, et al
    Deep Learning Based Lymph Node Gross Tumor Volume Detection via Distance-Guided Gating Using CT and 18F-FDG PET in Esophageal Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  159. WANG Y, Nie S, Chen J, Wang C, et al
    Nomograms Predicting Response and Survival of Esophageal Squamous Cell Carcinoma Patients Treated With Anti-PD-1 Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  160. WANG J, Wang J, Xiao LL, Wang S, et al
    Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy vs. Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  161. PETERS GW, Wang S, Peters NV, Dhanasopan A, et al
    Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  162. MORSE R, Mouw T, Moreno M, Dipasco P, et al
    Comparison of Postoperative Esophagectomy Outcomes in Esophageal Cancer Patients Receiving Preoperative Radiotherapy at an Academic Medical Center vs. Community Medical Centers.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  163. MIYAZAKI T, Myojin M, Takahashi H, Hosokawa M, et al
    The Role of Endoscopic Resection in Long-Term Results of Chemoradiotherapy for T1bN0M0 Thoracic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  164. POKHREL D, Bernard ME, Lockhart D, Jeremiah J, et al
    HyperArc VMAT SRT for Locally Recurrent Previously-Irradiated Head and Neck Cancers: Plan Quality, Treatment Delivery Accuracy and Efficiency.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  165. LYU B, Yin Y, Shi M, Zhao L, et al
    Long-Term Clinical Outcome and Safety Analysis of Superficial Esophageal Cancer Patients Receiving Definite or Adjuvant/Salvage Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  166. LIU J, Zeng X, Zhou X, Xu Y, et al
    Factors Associated with Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  167. LIN ZY, Cai WJ, Chen YY, Gao BZ, et al
    Survival Prediction of Esophageal Cancer Using 3D Residual Autoencoder and Proportional Hazards Model.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  168. AUTREY CM, Mittauer KE, Alvarez D, Chuong MD, et al
    MR-Guided Radiotherapy (MRgRT) for Laryngeal Cancer With Real-Time Visualization of Intrafraction Larynx Motion.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  169. SZEWCZYK C, Liao Y, Al-Khudari S, Jelinek M, et al
    A Novel Immobilization Method Using 3D Printing for the Treatment of Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  170. WU RY, Gao L, Huang X, Xiao J, et al
    Stereotactic Body Radiation Therapy for the First-Line Comprehensive Treatment of Oligometastatic Nasopharyngeal Carcinoma: A Prospective, Single-Arm, Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  171. HO YC, Lai YC, Lin HY, Lin JB, et al
    The Volume of Low-Dose Thoracic Irradiation Influences Systemic Inflammation-Immunity Status After Chemoradiation in Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  172. JAWORSKI E, Sun Y, Schonewolf C, Gharzai LA, et al
    Local Control With Cemiplimab Monotherapy for Unresectable Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  173. YANG GQ, Echevarria M, Caudell JJ
    Stereotactic Body Radiation Therapy (SBRT) With or Without Daily Systemic Therapy for Re-Irradiation of Unresectable, Recurrent, Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  174. CANAVAN JF, Campbell SR, Koyfman S, Woody NM, et al
    Second Primary Head and Neck Malignancies in Patients With Prior Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) Treated With Radiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  175. DOHOPOLSKI M, Wang K, Morgan HE, Chen L, et al
    Predicting Feeding Tube Placement in Head and Neck Cancer Patients Receiving Radiation Therapy With Machine Learning.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  176. IYER A, Steber C, Porosnicu M, Lycan T, et al
    Short-Course Palliative Radiotherapy Combined With Immunotherapy for Recurrent/Advanced/Metastatic Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  177. VEALE C, Boggs H, Liu Y, McDonald AM, et al
    Predictors of Ability to Complete Prescribed Concurrent Cisplatin Chemotherapy Regimen and Effect on Outcomes in Oropharyngeal Head and Neck Cancer Patients Treated With Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  178. KUTUK T, McAllister N, Rzepczynski AE, Young G, et al
    Submandibular Gland Transfer for the Prevention of Radiation Induced Xerostomia in Head and Neck Cancer - Dosimetric Impact With Intensity Modulated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  179. MAXWELL RJL, Poirier K, Montone K, Swisher-McClure SD, et al
    Detection of Plasma Circulating Tumor-Tissue Modified HPV DNA Following Trans-Oral Robotic Surgery (TORS) and Neck Dissection for p16+ Oropharyngeal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  180. SHER DJ, Avkshtol V, Moon D, Wang J, et al
    Recurrence and Quality-of-Life Following Involved Node Radiotherapy for Head and Neck Squamous Cell Carcinoma: Initial Results From the Phase II INRT-Air Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  181. LU DJ, Luu M, Gay C, Nguyen AT, et al
    Association of Pathologic Nodal Metastasis Count With Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of RTOG 9501, RTOG 0234, and EORTC 22931.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  182. SAHA S, Mallick I, Chatterjee S
    Adjuvant Radiation Therapy Nodal Target Volumes in Oral Cancer: Do Consensus Guidelines Reflect Patterns of Failure?
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  183. LOESER A, Abel J, Kutz LM, Krause L, et al
    Head and Neck Cancer Patients Under (Chemo-) Radiotherapy Undergoing NUTritional Intervention: Results From the Prospective Randomized HEADNUT-Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  184. LOKESH V, Ashalatha D, Naveen T, Vijay C, et al
    Effect of Bio Adhesive Barrier-Forming Oral Liquid on Oral Mucositis Severity and Duration in a Clinical Setting With Concurrent Chemo-Radiation for Patients With Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  185. GEORGE J, Vaughn J, Hobson M, Mittauer KE, et al
    ITV-Negation and Dose Fall-Off Features Result in OAR Dosimetric Superiority Favoring MR-Guided Radiotherapy (MRgRT), and Intensity Modulated Proton Therapy (IMPT) Over Volumetric Modulated Arc Therapy (VMAT) for Treatment of Distal Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  186. ZIYAN Z, Shen M, Jixi L, Kang L, et al
    Genome-Scale CRISPR-Cas9 Knockout Screening in Nasopharyngeal Carcinoma for Radiosensitive and Radioresistant Genes.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  187. YANG Y, Patel SH, Bridhikitti J, Wong WW, et al
    Seed Spots Analysis to Characterize Linear Energy Transfer (LET) Effect in the Adverse Event Regions of Head and Neck Cancer Patients Treated by Intensity Modulated Proton Therapy (IMPT).
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  188. ZHOU F, Wang J, Shayan G, Huang X, et al
    Prognostic Significance of Tumor Infiltrating Lymphocytes (TILs) and Programmed Cell Death-Ligand 1 (PD-L1) in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  189. LIU X, Wu B, Huang J, Ding Q, et al
    Patterns of Local-Regional Relapse Following Intensity-Modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  190. PENG X, Liu H, Yin Q, Lang J, et al
    Predictive Value of Ki-67 for Neoadjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  191. LU Y, Huang H
    Maintenance Intervention Improves Survival in Patients With Metastatic Nasopharyngeal Carcinoma Who Benefit From First-Line Treatment: A Prospective Multicenter Randomized Controlled Clinical Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  192. MILLER JA, Huang C, Sahoo MK, Wang H, et al
    Comparison of Multiplex Real-Time PCR and Droplet Digital PCR for Detection of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  193. MILLER JA, Sahoo MK, Huang C, Wang H, et al
    Multiplex Epstein-Barr Virus Genotyping PCR Detects High-Risk Variants in Plasma for Population-Level Nasopharyngeal Carcinoma Screening.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  194. LI Y, Liu Q, Zhu Y, Zang J, et al
    Induction Chemotherapy Followed by Concurrent Chemoradiotherapy vs. Concurrent Chemoradiotherapy in T4N0-1M0 Patients With Nasopharyngeal Carcinoma: A Multicenter Retrospective Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  195. SU H, Jin F, Li Y, Wu W, et al
    Comparative Analysis of Clinical Results of Compared With TPF Induction of Chemotherapy and PF Adjuvant Chemotherapy Combined With Cisplatin Radiochemotherapy for Locally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  196. JACINTO JKM, Huang SH, Su J, Kim J, et al
    Clinical Behavior and Outcome of HPV-Positive Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  197. XU H, Lu L, Lu T, Xu Y, et al
    Identifying the Optimal Candidates for the Best Utilization of Locoregional Radiation Therapy in Patients With De Novo Metastatic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  198. GUO Q, Xiao N, Xu H, Zong J, et al
    Evaluating the Rationality of the International Guideline's Recommendations Regarding Selective Coverage of Level Ib in Node Clinical Target Volume With Nasopharyngeal Carcinoma: Results From a Real-World Series.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  199. FENG M, Yin Q, Qi YX, Lu L, et al
    Low-Dose Ultra-Fractionated Radiotherapy as a Chemosensitizer of Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma: A Preliminary Results of the Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  200. CHOW JCH, Kitpanit S, Lee A, Bao K, et al
    Cranial Neuropathies in Advanced Nasopharyngeal Carcinoma: Neurological Recovery and Prognosis After Modern Radiotherapy and Systemic Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  201. CHUA MLK, Sim AYL, Ong EHW, Huang L, et al
    An Immune-Based Genomic Classifier (GC) Prognosticates for Survival in Endemic Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  202. CHENG WJ, Wan SL, Zhaodong F, Zhou Q, et al
    Automatic Gross Tumor Volume Delineation of Nasopharyngeal Carcinoma in 3D CT Images.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  203. FARRIS JC, Steber C, Chan MD, Cramer CK, et al
    IMRT With Planned Gamma Knife Radiosurgery Boost for Head and Neck Cancer With Extensive Disease in Proximity to Critical Structures.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  204. VALLE L, Chu FI, Erman A, Hernandez J, et al
    Patient-Reported Quality of Life Outcomes After Integrating Exclusive Liquid Meal Replacement in Patients With Head and Neck Cancer Undergoing Chemoradiation: Results From a Phase II Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  205. RUHLE A, Stromberger C, Haehl E, Senger C, et al
    Development and External Validation of a Prognostic Classifier for Elderly Head-and-Neck Cancer Patients Undergoing (Chemo)radiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  206. STEBER C, Russell G, Rush MC, Shenker RF, et al
    Impact of Treatment Timing on Disease Outcomes in Patients Treated With Definitive Concurrent Chemoradiation for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  207. AULAKH SS, Dyer BA, Rao SSD
    Evaluation of Risk Factors for Developing Hypothyroidism Following Radiation Therapy for Head and Neck Cancers.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  208. O'KEEFE R, LaRiviere MJ, Vachani C, Hampshire MK, et al
    Contribution of Family History of Head and Neck Cancer and Associated Risk Factors: Analysis of an Internet Based Risk Assessment Tool.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  209. NG SP, Martin GV, Guha-Thakurta N, Wang H, et al
    Patterns of Failure After IMRT and Proton Re-Irradiation for Patients With Recurrent Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  210. LENZIE A, Hoyle J, Yang ES, Spencer SA, et al
    Pain, Weight Loss, and Quality of Life in a Supportive Care Trial for Patients With Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  211. MORENO AC, Wang XA, Mohamed AS, Wang H, et al
    Patterns of Failure After SBRT Reirradiation for Recurrent Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  212. KUT C, McNutt TR, Lee J, Sheikh K, et al
    Spatial Dose Sparing for Organs-at-Risk (OARs) to Decrease Severe Lymphopenia Risks in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  213. LEE J, Lee JJB, Lee CG Jr
    Outcome of Dental Extraction and Implants in Irradiated Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  214. KRC RF, Singh S, Weir JS
    Photobiomodulation Laser Therapy During Chemoradiation for Head and Neck Cancer: Effect on Mucositis, Weight Loss, and Feeding Tube Dependence.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  215. KIM M, Narinesingh D, Hamm J, Marwaha A, et al
    Radiation Therapy in Elderly Patients With Squamous Cell Carcinoma of the Head and Neck - Insights From Real World Registry DATA (2007-2017).
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  216. JAWORSKI E, Sun Y, Vineberg KA, Mierzwa ML, et al
    Dosimetric Analysis for Predicting Secondary Lymphedema After Radiation for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  217. KIM K, Doucette A, Amaniera I, Baumann BC, et al
    Acute Toxicity in Patients Treated With Proton vs. Photon Chemoradiotherapy for Locally Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  218. HUSAIN ZA, Chen H, Biswas T, Dagan R, et al
    Outcomes for Oligometastatic Head and Neck Cancer Undergoing SBRT: Results From an International Multi-Institutional Consortium.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  219. ECHEVARRIA M, Chung C, Kirtane K, Kish JA, et al
    Outcomes of Phase I Trial of Patients With Recurrent Head and Neck Squamous Cell Carcinoma Treated With Re-Irradiation With Stereotactic Body Radiation Therapy and Concurrent Cisplatin.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  220. DHAKAL A, Mladkova N, Blakaj DM
    Divergent Role of Intermediate Filaments in Clinical Outcomes of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  221. DOOLEY S, Tobillo R, de Joya E, Freedman LM, et al
    Destructive-Type TP53 Mutations are Independently Associated With Worse Overall Survival in Patients With HPV-Negative Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  222. SCHLAFSTEIN A, Goyal S, Amini A, Karam SD, et al
    Does Operability Status Influence Outcomes in Patients With T4 Larynx Cancer Undergoing Larynx Preservation?
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  223. OTSUKA M, Yasuda K, Minatogawa H, Fujita Y, et al
    A Dosimetric Analysis of Locoregional Failure Using Deformable Image Registration in Hypopharyngeal Cancer After Sequential-Boost Intensity-Modulated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  224. LUO X, Yi J, Wang J, Wu R, et al
    Hypopharyngeal Carcinoma With Synchronous and Metachronous Multiple Malignancies: Clinical Characteristics and Prognosis Analysis of 673 Real World Cases.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  225. GONG H, Zhang T, Li M, Peng S, et al
    Radical Surgery vs. Definitive Concurrent Chemoradiotherapy for Locally Advanced Hypopharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  226. LUO X, Yi J, Wu R, Huang X, et al
    Response-Adapted Strategy Based on Early Response to Radiotherapy Achieves Favorable Survival With Functional Larynx in Resectable, Locally Advanced Hypopharyngeal Cancer: An Analysis of 423 Real-World Cases.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  227. ANDERSON E, Luu M, Lu DJ, Chung EM, et al
    Predicting Pathologic Lymph Node Positivity in cN0 Pharynx and Larynx Cancers in the Modern Imaging Era.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  228. FRANKART AJ, Sadraei NH, Huth B, Redmond KP, et al
    Concurrent Immunotherapy With Chemoradiation for Definitive Management of Locally Advanced Laryngeal Cancer: A Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  229. SABA NF, Wong S, Stokes WA, Rupji M, et al
    CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  230. SHI Z, Zhu X, Ke S, Qiu H, et al
    Clinical Parameters Predicting Prognosis for Elderly Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  231. MLADKOVA N, Blakaj DM, Raval R
    Patterns of Care for Incarcerated Head and Neck Cancer Patient Receiving Radiation: A Single-Center Retrospective Descriptive Cohort Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  232. CHANG X, Zhang W, Yang J, Yu S, et al
    Recurrence Risk Stratification Based on Competing-Risks Nomograms to Identify Patients With Esophageal Cancer Who May Benefit From Postoperative Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  233. SUMNER W, Ray X, Sutton L, Rebibo D, et al
    Genetic Alterations as Predictors of Radiation-Induced Toxicity in Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  234. WANG L, Cao JZ, Wang X, Li Y, et al
    The Molecular Effects of a PARP-1/-2 Inhibitor on Proton and Photon Radiotherapy in Head and Neck Cancer Cells.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  235. ZHAO C, Meng X, Jin F, Li Y, et al
    We Hypothesize That BMAL1 Has a Positive Regulatory Effect on the Radiosensitivity of Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  236. DONG J, Wen B, Wang C, Zhang T, et al
    Application of Hypoxia-Driven Dual-Reporter Model to Explore the Effect of Hypoxia on Radiosensitivity of Human Nasopharyngeal Carcinoma Cells.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  237. ROVEDA J, Murdaugh DL, McConathy JE, Milner D, et al
    Brain Glucose Metabolism is Reduced After Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  238. TOBILLO R, de Joya E, Dooley S, Freedman LM, et al
    Female Sex and Increased Immune Marker mRNA Gene Expression are Associated With Decreased Overall Survival in Patients With HPV-Negative Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  239. WANG Y, Li T, Lv J, Xiao L, et al
    Mechanism of Increased Treg Frequency Induced by Irradiated Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  240. JIN F, Chen Y, Jiang Z, Li Y, et al
    The Correlation Study of Circadian Clock Gene BMAL1 Regulates the Biological Behavior of Human Nasopharyngeal Carcinoma Cell After Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  241. HOYLE J, Lenzie A, Kenzik K, Ward K, et al
    Patient Factors Associated With Loss to Radiation Oncology Specialty Follow-Up Among Head and Neck Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  242. MAYO ZS, Ilori E, Fleming CW, Woody NM, et al
    Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy (H-IMRT) for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  243. COKE A, Gilbert M, Hill S, Siddiqui F, et al
    A Multidisciplinary Approach to the Reactive Placement of Nasogastric Feeding Tubes in Clinic During Treatment for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  244. DING S, Liu H, Wang B, Li Y, et al
    Assessment of Dose Accuracy for MR-Guided Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  245. ZAHID MU, Caudell JJ, Moros EG, Mohamed AS, et al
    In Silico Trial to Estimate Personalized RT Dose in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  246. OLSSON CE, Raunert I, Pauli N, Tuomi L, et al
    Feasibility of Mastication-Structure-Sparing Radiotherapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  247. ABUSAIF A, Moawad A, van Dijk LV, Fuentes D, et al
    Radiomic Correlates of Mandibular Osteoradionecrosis After Radiation Treatment of Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  248. GUPTA H, Deek MP, McNutt TR, Lee J, et al
    Predicting Progression-Free Survival Using Primary and Nodal Radiomic Features in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  249. CHEN Q, Bernard ME, Duan J, Feng X, et al
    A Transfer Learning Approach for Improving OAR Segmentation in the Adaptive Therapy or Retreatment of Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  250. DING M, Cui H, Li B, Zou B, et al
    Integrating Preoperative CT and Clinical Factors for Lymph Node Metastasis Prediction in Esophageal Cancer by Feature-Wise Attentional Graph Neural Network (FAGNN).
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  251. MORGAN HE, Wang K, Dohopolski M, Liang X, et al
    Explainable Boosting Machine Model with a Parallel Ensemble Design Predicts Local Failure for Head and Neck Cancer With Clinical, CT, and Delta CBCT Radiomic Features.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  252. PIFER P, Kumar M, Yang L, Xie T, et al
    Focal Adhesion Kinase Drives Resistance to Therapy in HPV-Negative Head and Neck Squamous Cell Carcinoma in a p53-Dependent Manner.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  253. MAYO C, Mierzwa ML, Medlin R, Casper K, et al
    Anticipating Poor Outcomes: A Prognostic Machine Learning Model of Unplanned Visits to the Emergency Department for Patients Undergoing Treatment for Head and Neck Cancer Using Comprehensive Multi-Factor Electronic Health Records.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  254. LIU F, Fu SN, Chen YZ, Yan OY, et al
    A Randomized Controlled Trial of Reirradiation Using Diffusion-Weighted MRI Guided Dose-Painting vs. CT-Based Radiotherapy for Locally Recurrent T3 to T4 Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  255. NICOLAY NH, Ruhle A, Mix M, Wiedenmann N, et al
    Development of a Hypoxia-Immune Prognostic Classifier for Head-and-Neck Cancer Patients Undergoing Radiotherapy - Results From a Prospective Imaging Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  256. MIERZWA ML, Lee C, Schipper M, Aryal MP, et al
    Randomized Phase II Study of DCE-MRI-Based Dose Escalation for Poor-Prognosis Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  257. LEE YS, Bradley ST, Gurel Z, Nickel KP, et al
    Mitophagy Induction by ROS-PINK1 Signaling Protects Head and Neck Cancer From Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  258. POLAN D, Mierzwa ML, Epelman M, Sun Y, et al
    Prioritized Optimization of Total Toxicity Burden for Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  259. CREHANGE G, M'vondo C, Bertaut A, Pereira R, et al
    Exclusive Chemoradiotherapy With or Without Radiation Dose Escalation in Esophageal Cancer: Multicenter Phase 2/3 Randomized Trial CONCORDE (PRODIGE-26).
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  260. FENG M, Yan L, Du X, Wang H, et al
    Early Efficacy Prediction of Nasopharyngeal Carcinoma Based on 3D-ADC Acquired During Radiotherapy: A Phase II Prospective Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  261. BRIZEL DM, Mowery YM, Zhen W, Chan J, et al
    A Phase 1-2 Trial of Concurrent Radiation Therapy, Cisplatin and BMX-001 in Locally Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  262. QIAN DC, Ulrich BC, Peng G, Zhao H, et al
    Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-Treatment DNA Methylation in Peripheral Blood.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  263. XIANG L, Wu J
    Five-Year Result After Reduction of the Target Volume of Intensity Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase 3, Multicenter, Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  264. LIU F, Fu SN, Yan OY, Chen YZ, et al
    A Randomized Controlled Trial of Cognitive Behavior Therapy for Reducing Anxiety and Depressive Symptoms in Patients With Locally Recurrent Nasopharyngeal Carcinoma Receiving Reirradiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

  265. CAI G, Yu J, Meng X
    Dosimetric Predictors of Cardiac Events After Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    >> Share

    October 2021
  266. RABEN D, Raben A
    A Two-Headed Heated Debate.
    Int J Radiat Oncol Biol Phys. 2021;111:310.
    >> Share

  267. SIT D, Koh WX, Shokoohi A, Raycraft T, et al
    External Beam Radiation Therapy in pT4 Well-Differentiated Thyroid Cancer: A Population-Based Study of 405 Patients.
    Int J Radiat Oncol Biol Phys. 2021;111:468-478.
    >> Share

  268. LI Y, Liu H, Sun C, Yin X, et al
    Comparison of Clinical Efficacy of Neoadjuvant Chemoradiation Therapy Between Lower and Higher Radiation Doses for Carcinoma of the Esophagus and Gastroesophageal Junction: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2021;111:405-416.
    >> Share

    September 2021
  269. STEENBAKKERS RJHM, van Rijn-Dekker MI, Stokman MA, Kierkels RGJ, et al
    Parotid gland stem cell sparing radiotherapy for head and neck cancer patients: a double-blind randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2021 Sep 23. pii: S0360-3016(21)02827.
    >> Share

  270. VISSER S, den Otter LA, Ribeiro CO, Korevaar EW, et al
    Diaphragm Based Position Verification to Improve Daily Target Dose Coverage in Proton and Photon Radiotherapy Treatment of Distal Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Sep 13. pii: S0360-3016(21)02814.
    >> Share

  271. INDELICATO DJ, Dagan R
    A Young Patient with EBV-Positive Nasopharyngeal Carcinoma: Dissonance of Dose, Variance of Volume, and Tussle of Timing.
    Int J Radiat Oncol Biol Phys. 2021;111:9-10.
    >> Share

  272. WU CC, Krasin MJ
    Management of Pediatric Nasopharyngeal Carcinoma: A Role for RT Dose De-escalation.
    Int J Radiat Oncol Biol Phys. 2021;111:11.
    >> Share

  273. MIERZWA M, Beadle BM, Chua MLK, Ma DJ, et al
    Something for Everyone From Low-Risk to High-Risk: 5 Recent Studies to Improve Treatment and Surveillance for All Patients With Squamous Cell Carcinoma of the Head and Neck.
    Int J Radiat Oncol Biol Phys. 2021;111:1-8.
    >> Share

  274. LOIZEAU N, Fabiano S, Papp D, Stutzer K, et al
    Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:196-207.
    >> Share

    August 2021
  275. NAZ S, Leiker AJ, Choudhuri R, Preston O, et al
    Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis.
    Int J Radiat Oncol Biol Phys. 2021;110:1295-1305.
    >> Share

  276. BISHOP AJ, Livingston JA, Ning MS, Valdez ID, et al
    Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2021;110:1496-1504.
    >> Share

  277. PRASANNA PG, Rawojc K, Guha C, Buchsbaum JC, et al
    Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:1325-1340.
    >> Share

    June 2021
  278. ENGESETH GM, He R, Mirkovic D, Yepes P, et al
    Mixed effect modelling of dose and Linear Energy Transfer correlations with brain image changes after intensity modulated proton therapy for skull base head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jun 18. pii: S0360-3016(21)00734.
    >> Share

  279. ZAHID MU, Mohsin N, Mohamed ASR, Caudell JJ, et al
    Forecasting Individual Patient Response to Radiotherapy in Head and Neck Cancer with a Dynamic Carrying Capacity Model.
    Int J Radiat Oncol Biol Phys. 2021 Jun 5. pii: S0360-3016(21)00676.
    >> Share

  280. YOKOTA T, Zenda S, Ota I, Yamazaki T, et al
    Phase 3 randomized trial of topical steroid versus placebo for prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiation.
    Int J Radiat Oncol Biol Phys. 2021 Jun 5. pii: S0360-3016(21)00677.
    >> Share

  281. THOMPSON LMA, Donovan KA
    Discussions About Sexual Health: An Unmet Need Among Patients With Human Papillomavirus-Related Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:394-395.
    >> Share

  282. KOTHE A, van Luijk P, Safai S, Kountouri M, et al
    Combining Clinical and Dosimetric Features in a PBS Proton Therapy Cohort to Develop a NTCP Model for Radiation-Induced Optic Neuropathy.
    Int J Radiat Oncol Biol Phys. 2021;110:587-595.
    >> Share

  283. TAKEMOTO N, Seo Y, Nakahara S, Yoshioka Y, et al
    Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.
    Int J Radiat Oncol Biol Phys. 2021;110:403-411.
    >> Share

  284. WADDLE MR, Ma DJ, Visscher SL, Borah BJ, et al
    Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.
    Int J Radiat Oncol Biol Phys. 2021;110:396-402.
    >> Share

  285. MIERZWA ML, Gharzai LA, Li P, Wilkie JR, et al
    Early MRI Blood Volume Changes in Constrictor Muscles Correlate With Postradiation Dysphagia.
    Int J Radiat Oncol Biol Phys. 2021;110:566-573.
    >> Share

  286. CASSWELL G, Gough K, Drosdowsky A, Bressel M, et al
    Sexual Health and Interpersonal Relationships After Chemoradiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A Cross-sectional Study.
    Int J Radiat Oncol Biol Phys. 2021;110:382-393.
    >> Share

    May 2021
  287. VANDEN BOSCH L, van der Laan HP, van der Schaaf A, Oosting SF, et al
    Patient-reported toxicity and quality of life profiles in head and neck cancer patients treated with definitive radiotherapy or chemoradiation.
    Int J Radiat Oncol Biol Phys. 2021 May 25. pii: S0360-3016(21)00656.
    >> Share

  288. WANG L, Gao Z, Li C, Sun L, et al
    Computed tomography-based delta-radiomics analysis for discriminating radiation pneumonitis in patients with esophageal cancer after radiation therapy.
    Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00475.
    >> Share

  289. MOLLER DS, Poulsen PR, Hagner A, Dufour M, et al
    Strategies for motion robust proton therapy with pencil beam scanning of esophageal cancer.
    Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00468.
    >> Share

  290. VAN DIJK LV, Abusaif AA, Rigert J, Naser MA, et al
    Normal Tissue Complication Probability (NTCP) prediction model for osteoradionecrosis of the mandible in head and neck cancer patients following radiotherapy: Large-scale observational cohort.
    Int J Radiat Oncol Biol Phys. 2021 May 6. pii: S0360-3016(21)00470.
    >> Share

  291. GRIMM J, Vargo JA, Mavroidis P, Moiseenko V, et al
    Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
    Int J Radiat Oncol Biol Phys. 2021;110:147-159.
    >> Share

    April 2021
  292. XIAO C, Miller AH, Peng G, Levine ME, et al
    Association of epigenetic age acceleration with risk factors, survival, and quality of life in patients with head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2021 Apr 18. pii: S0360-3016(21)00362.
    >> Share

  293. FRANKART AJ, Frankart MJ, Cervenka B, Tang AL, et al
    Osteoradionecrosis: Exposing the Evidence Not the Bone.
    Int J Radiat Oncol Biol Phys. 2021;109:1206-1218.
    >> Share

  294. VAN LIMBERGEN EJ, Hoeben A, Lieverse RIY, Houben R, et al
    Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1421-1430.
    >> Share

    March 2021
  295. LUITJE ME, Israel AK, Cummings MA, Giampoli EJ, et al
    Long-Term Maintenance of Acinar Cells in Human Submandibular Glands After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:1028-1039.
    >> Share

  296. BUSZEK SM, Ludmir EB, Grosshans DR, McAleer MF, et al
    Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2021;109:718-725.
    >> Share

  297. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    >> Share

  298. DENG J, Dietrich MS, Niermann KJ, Sinard RJ, et al
    Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom Inventory.
    Int J Radiat Oncol Biol Phys. 2021;109:747-755.
    >> Share

    February 2021
  299. LIU WS, Tsai KW, Kang BH, Yang CC, et al
    Simultaneous Reduction of Volume and Dose in Clinical Target Volume for Nasopharyngeal Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;109:495-504.
    >> Share

    January 2021
  300. MCDOWELL L, Rischin D, Lee AWM
    Locoregional Radiation Therapy for De Novo Metastatic Nasopharyngeal Cancer: One Size Fits All?
    Int J Radiat Oncol Biol Phys. 2021;109:131-133.
    >> Share

  301. ANKER CJ, Dragovic J, Herman JM, Bianchi NA, et al
    Executive Summary of the American Radium Society Appropriate Use Criteria for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines.
    Int J Radiat Oncol Biol Phys. 2021;109:186-200.
    >> Share

    December 2020
  302. FANG P, Gunther JR, Pinnix CC, Dong W, et al
    A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Dec 9. pii: S0360-3016(20)34644.
    >> Share

  303. MOHAMED ASR, He R, Ding Y, Wang J, et al
    Quantitative Dynamic Contrast-Enhanced MRI Identifies Radiation-Induced Vascular Damage in Patients With Advanced Osteoradionecrosis: Results of a Prospective Study.
    Int J Radiat Oncol Biol Phys. 2020;108:1319-1328.
    >> Share

    November 2020
  304. DYER BA, Mayadev JS
    Restage and Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2020;108:849-850.
    >> Share

  305. MOWERY YM, Vergalasova I, Rushing CN, Choudhury KR, et al
    Early (18)F-FDG-PET Response During Radiation Therapy for HPV-Related Oropharyngeal Cancer May Predict Disease Recurrence.
    Int J Radiat Oncol Biol Phys. 2020;108:969-976.
    >> Share

  306. CHOU WC, Yeh KY, Chang PH, Lu CH, et al
    In Reply to Chow et al.
    Int J Radiat Oncol Biol Phys. 2020;108:832-834.
    >> Share

  307. CHOW JCH, Cheung KM, Bao KKH, Leung AKC, et al
    In Regard to Chou et al.
    Int J Radiat Oncol Biol Phys. 2020;108:831-832.
    >> Share

  308. DHARMARAJAN KV, Mohile SG
    Can Geriatric Assessment Measures Be Used to Determine Cancer Treatment Vulnerability in Nongeriatric Patients?
    Int J Radiat Oncol Biol Phys. 2020;108:612-614.
    >> Share

  309. PRICE JG, Spiegel DY, Yoo DS, Moravan MJ, et al
    Development and Implementation of an Educational Simulation Workshop in Fiberoptic Laryngoscopy for Radiation Oncology Residents.
    Int J Radiat Oncol Biol Phys. 2020;108:615-619.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016